The contribution of glucose variability to asymptomatic hypoglycemia in persons with type 2 diabetes

Monnier, Louis, Wojtusciszyn, Anne, Colette, Claude and Owens, David Raymond 2011. The contribution of glucose variability to asymptomatic hypoglycemia in persons with type 2 diabetes. Diabetes Technology & Therapeutics 13 (8) , pp. 813-818. 10.1089/dia.2011.0049

Full text not available from this repository.

Abstract

Background: The present study was designed to define the relative contributions of glucose variability and ambient glycemia to the incidence of asymptomatic hypoglycemia in type 2 diabetes. Methods: Two hundred twenty-two persons with type 2 diabetes were divided into three groups: Group I (n = 53) on insulin sensitizers alone, Group II (n = 87) on oral hypoglycemic agents (OHAs) to include at least one insulin secretagogue, and Group III (n = 82) on insulin alone or in combination with OHAs. Ambient mean glucose concentration (MG) values (in mmol/L) and glycemic variability (SD around the mean glucose value) (in mmol/L) or mean amplitude of glycemic excursions (in mmol/L) were assessed by a continuous glucose monitoring system. Asymptomatic hypoglycemia was recorded over a 48-h period. Poisson regression analysis was used for assessing the potential predictors of hypoglycaemia. Results: The best model fit was obtained with the two following explanatory variables: MG and SD. Hypoglycemia frequency was negatively associated with MG and positively with SD: Log (number of hypoglycemia episodes) = 1.37 − (0.72 × MG) + (1.33 × SD). Odds ratios (95% confidence interval) for hypoglycemic risk were significantly different from 1 for MG at 0.96 (0.95–0.97) (P < 0.0001) and for SD at 1.08 (1.06–1.10) (P < 0.0001). In addition, the risk for hypoglycemia was completely or virtually eliminated when the SD was <1.7 mmol/L irrespective of the ambient glucose level and treatment modality. Conclusions: As the risk of asymptomatic hypoglycemia increases in the presence of increased glucose variability, avoidance of excess glucose fluctuations should be an important consideration for either reducing or preventing the risk of hypoglycemia in type 2 diabetes.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Subjects:	R Medicine > RA Public aspects of medicine R Medicine > RM Therapeutics. Pharmacology
Publisher:	Mary Ann Liebert
ISSN:	1520-9156
Last Modified:	04 Jun 2017 03:43
URI:	https://orca.cardiff.ac.uk/id/eprint/25462

Citation Data

Cited 126 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item